首页> 中文期刊> 《肾脏病与透析肾移植杂志》 >高截留量血液透析临床应用进展

高截留量血液透析临床应用进展

         

摘要

高截留量膜最初用于清除严重脓毒症的炎症介质,近年来被用于治疗骨髓瘤管型肾病、横纹肌溶解等疾病,并有望用于终末期肾病患者大分子毒素的清除.本文就高截留量膜的定义、理论基础、高截留量血液透析相关技术及临床应用进展作一简述.%Initially designed to remove the inflamamatory mediators in the patients with severe sepsis,high cut-off membranes have being applicated in the treatment of myeloma kidney and rhabdomyolysis. Furthermore, high cut-off membranes have a potential for the removal of uremic toxins with large molecules in the patients with .end-stage renal disease. This review is to summarize the definition, rational, techniques and advancement in the clinical application of high cut-off membranes.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号